NewsNovel Molecules Designed by Artificial Intelligence in 21 Days Are Validated in Miceby Insilico MedicineExperimental validation confirms the ability of artificial intelligence to accelerate drug discovery
NewsEpigenetic Markers of Ovarian Cancerby Insilico MedicineJohn Hopkins researchers, in collaboration with Insilico Medicine, identify that silencing of the GULP1 gene expression by methylation plays an important role in ovarian carcinogenesis
Leading Artificial Intelligence Companies Partner on a Quest to Solve Duchenne Muscular Dystrophyby Insilico Medicine,A2A PharmaceuticalsInsilico Medicine announced a research collaboration agreement with A2A Pharmaceuticals, Inc